Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs hydroxyzine for pruritus in advanced solid cancer patients treated with EGFR inhibitors
TCTR20170929004Phase 3Not yet recruiting
- Sponsor
- n/a
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bilastine, hydroxyzine in pruritus, sponsored by n/a. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
bilastinehydroxyzine
03
Conditions
pruritus
Beyond the preview
Go deeper on TCTR20170929004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170929004.